SANDOZ RIVAROXABAN

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 0403f5eb2e554f72
Drug Approval Canada Name: SANDOZ RIVAROXABAN
Product Name: SANDOZ RIVAROXABAN
Status: Marketed
Status Date: 2023-11-01
Original Market Date: 2023-11-01
Din: 02482258
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF01 RIVAROXABAN
Atc Name: b 01 af 01
Aig Number: 0152487003
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

RIVAROXABAN

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0403f5eb2e554f72

Type

Standard